• OPEN AN ACCOUNT
Indian Indices
Sensex
82,532.19 427.40
( 0.52%)
Global Indices
Nasdaq
51,667.44 -701.11
(-1.34%)
Dow Jones
7,446.91 -135.76
(-1.79%)
Hang Seng
58,984.34 -677.68
(-1.14%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
94.26 0.34
(0.36%)
EUR-INR
103.88 -0.12
(-0.12%)
GBP-INR
124.50 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.38%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
686.0527542
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
36.31
55758.82
EPS(TTM)
Face Value()
Div & Yield %
93.05
1
0.59
 

Mahindra & Mahindra to invest up to Rs 1450 cr in rights issue of SML Mahindra
Nov 06,2026
Mahindra & Mahindra, on 06 November 2026, has approved subscription to the rights issue of SML Mahindra to the full extent of its rights entitlement, aggregating ~Rs. 855 crore.

The company also approved subscription to additional equity shares and/or any portion of the rights issue that remains unsubscribed, if any, beyond the company's entitlement, aggregating ~Rs. 595 crore.